We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

3-week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07009)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00159796
First Posted: September 12, 2005
Last Update Posted: May 31, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Pfizer
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.